This study aimed to explore the client experience of long-term opiate substitution treatment (OST).
Methods
A qualitative grounded theory study set in a UK rural community drug treatment service.
Results
Continuous OST enabled stability and a sense of “normality.” Participants expressed relief at moving away from previous chaotic lifestyles and freedom from the persistent fear of opiate withdrawal. However, for some, being on a script made them feel withdrawn, lethargic, and unable to fully participate in mainstream society. Intrapersonal barriers (motivation and fear) were perceived as key barriers to abstinence.
Conclusions
Participants experienced long-term OST as a transition between illicit drug use and recovery. Recovery was seen as a process rather than a fixed goal, confirming that there is a need for services to negotiate individualized recovery goals, spanning harm minimization and abstinence-oriented treatment approaches.
StrangJ, BaborT, CaulkinsJ, FischerB, FoxcroftD, HumphreysK. Drug policy and the public good: evidence for effective interventions. Lancet.2012;379:71–83.
2.
National Treatment Agency for Substance Misuse. Medications in Recovery—Re-Orientating Drug Dependence Treatment. London: National Treatment Agency for Substance Misuse; 2012.
3.
WardJ, Mattick RP, Hall W. Maintenance Treatment and Other Opioid Replacement Therapies. London: Harwood Academic Publishers; 1998.
4.
MarschLA. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behaviour and criminality: a meta-analysis. Addiction. 1998;93:515–532.
5.
World Health Organization (WHO), ed. Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. Geneva: World Health Organization; 2009.
6.
StrangJ, ToberG.Methadone: panacea or poison. In: StrangJ, ToberG, ed. Methadone Matters: Evolving Community Methadone Treatment of Opiate Addiction. London: Martin Dunitz; 2003:3–12.
7.
Home Office. Putting Full Recovery First—The Recovery Roadmap. London: Home Office; 2012.
8.
National Treatment Agency for Substance Misuse, ed. Towards Successful Treatment Completion; A Good Practice Guide. London: National Treatment Agency for Substance Misuse; 2009.
9.
National Treatment Agency for Substance Misuse (NTA), ed. NTA Business Plan 2010–11. London: National Treatment Agency for Substance Misuse; 2010.
National Institute on Drug Abuse, ed. Principles of Drug Addiction Treatment: A Research Based Guide. 2nd ed. Bethesda, MD: National Institute on Drug Abuse; 2009.
12.
World Health Organization, ed. ATLAS on Substance Use (2010): Resources for Prevention and Treatment of Substance Use Disorders. Geneva: World Health Organization; 2010.
13.
Home Office, ed. Drug Strategy 2010: ‘Reducing Demand, Restricting Supply, Building Recovery: Supporting People to Live a Drug-Free Life’. London: HM Government; 2010.
14.
UK Drug Policy Commission, ed. Commissioning for Increased Recovery: Lessons From a UKDPC Seminar. London: UK Drug Policy Commission; June 2012.
15.
HM Government, Inter-Ministerial Group on Drugs, ed. Putting Full Recovery First. London: HM Government; 2012.
16.
WhiteWL.Recovery capital: a primer for addictions professionals. Counselor. 2008;9:22–27.
17.
National Treatment Agency for Substance Misuse, ed. Building Recovery In Communities: A Summary of the Responses to the Consultation. London: National Treatment Agency for Substance Misuse; 2012.
18.
The UK Drug Policy Commission Recovery Consensus Group, ed. A Vision of Recovery. UKDPCH Policy report; 2008.
19.
GossopM, MarsdenJ, StewartD, KiddT.The National Treatment Outcome Research Study (NTORS): 4–5 year follow-up results. Addiction.2003;98:291–303.
20.
National Treatment Agency for Substance Misuse (NTA), ed. NTA Facts and Figures. 2010.
21.
CalabriaB, DegenhardtL, BrieglebC, . Systematic review of prospective studies investigating “remission” from amphetamine, cannabis, cocaine or opioid dependence. Addict Behav.2010;35:741–749.
22.
HunterM.Risks from forced detoxification from heroin are being ignored, conference hears. BMJ.2011;343:d6116.
23.
NealeJ, NettletonS., PickeringL.What is the role of harm reduction when drug users say they want abstinence?Int J Drug Policy.2011;22:189–193.
24.
NotleyC, BlythA, MaskreyV, CraigJ, HollandR.The experience of long term opiate maintenance treatment and reported barriers to recovery: a qualitative systematic review. Eur Addict Res.2013;19:287–298.
25.
De MaeyerJ, VanderplasschenW, CamfieldL, . A good quality of life under the influence of methadone: a qualitative study among opiate-dependent individuals. Int J Nurs Stud.2011;48:1244–1257.
26.
FingletonN, MathesonC, JaffrayM.Changes in mental health during opiate replacement therapy: a systematic review. Drugs Educ Prev Policy. 2015, 22:1–18.
27.
JarvinenM.Approaches to methadone treatment: harm reduction in theory and practice. Sociol Health Illn.2008;30:975–991.
28.
Glaser BG, Strauss AL. The Discovery of Grounded Theory: Strategies for Qualitative Research. Chicago: Aldine Publishing Company; 1967.
De MaeyerJ, VanderplasschenW, BroekaertE.Quality of life among opiate-dependent individuals: a review of the literature. Int J Drug Policy.2010;21:364–380.
31.
AndersonTL, LevyJA. Marginality among older injectors in today's illicit drug culture: assessing the impact of ageing. Addiction. 2003;98:761–770.
HoltM.Agency and dependency within treatment: drug treatment clients negotiating methadone and antidepressants. Soc Sci Med. 2007;64:1937–1947.
34.
HarrisJ, McElrathK.Methadone as social control: institutionalised stigma and the prospect of recovery. Qual Health Res. 2012;22:810–824.
35.
CorriganPW, WatsonAC. The paradox of self-stigma and mental illness. Clin Psychol Sci Pract. 2002;9:35–53.
36.
LinkBG, PhelanJC. Stigma and its public health implications. Lancet. 2006;367:528–529.
37.
LinkBG, StrueningEL, Neese-ToddS, AsmussenS, PhelanJC. Stigma as a barrier to recovery: the consequences of stigma for the self-esteem of people with mental illnesses. Psychiatr Serv. 2001;52:1621–1626.
38.
LloydC.Sinning and Sinned Against: The Stigmatisation of Problem Drug Users. York, UK: University of York; 2010.
39.
BestD, RomeA, HanningKA, . Research for Recovery: A Review of the Drugs Evidence Base. Research Findings No.23/2010. Edinburgh: Scottish Government; 2010.
40.
Galvanni S, Forrester D. Social Work Services and Recovery from Substance Misuse—A Review of the Evidence, Practitioners Guide. London: Association of Directors of Social Work; 2010.
41.
National Treatment Agency for Substance Misuse (NTA). Recovery-Orientated Drug Treatment: An Interim Report by Professor John Strang, Chair of the Expert Group. London: National Treatment Agency for Substance Misuse; 2011.
